China, UK seek closer cooperation in healthcare

Resumen detallado
Photo provided to China Daily] The second China-UK Health Innovation Dialogue in London, England, on Monday brought together government officials, regulators, business leaders,…
The second China-UK Health Innovation Dialogue in London, England, on Monday brought together government officials, regulators, business leaders, and academics from both countries to explore opportunities for closer cooperation in healthcare.
The event is part of London Life Sciences Week, an annual citywide offering that was expected to draw more than 5,000 attendees.
Co-hosted by the China Investment Promotion Agency under the Ministry of Commerce and the UK's Department for Business, Innovation, Science and Trade, the event was held under the China-UK Health Innovation Platform, an initiative agreed to at the 11th China-UK Economic and Financial Dialogue.
The platform aims "to establish a long-term, efficient and practical mechanism, guided by governments and driven by the market, for bilateral healthcare cooperation", said Tang Song, deputy director of the China Investment Promotion Agency.
The inaugural health dialogue took place in Beijing in 2025. Working groups on mental health and the silver economy have since been established.
At the 25th China International Fair for Investment and Trade in Xiamen, where the UK was the guest country of honor, the platform also supported matchmaking events and high-level dialogues, with major deals in healthcare reached.
Appetite for two-way exchanges is accelerating, particularly as China is rising as a global powerhouse in health innovation, industry insiders told China Daily at the event.
"China's most striking progress in healthcare in recent years has been the speed at which research is translated into clinical applications and commercial products," said Wen Tianyu, director of business development at China's Thalys Medical Technology Group. "Advances in materials, precision manufacturing, and supply chain management have significantly shortened the journey from laboratory prototype to mass production.
"Moreover, Chinese companies are increasingly developing innovative drugs at home and bringing them to international markets…
Inicio del artículo, extracto de China Daily. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.chinadaily.com.cn)


